Knowing What You Don’t Know: Utilizing Medical Affairs to Facilitate Patient-Centric Drug Development
Time: 4:30 pm
day: Day Two
Details:
- Developing medical affairs teams to enter into new therapeutic areas
- Benefits of patient engagement early in the development process
- Bringing an epigenetic therapy into a gene therapy treatment landscape
